References
- Kuriakose D, Xiao Z. Pathophysiology and treatment of stroke: present status and future perspectives. Int J Mol Sci. 2020;21:7609. https://doi.org/10.3390/ijms21207609
- Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, et al. Heart disease and stroke statistics-2022 update: a report from the american heart association. Circulation. 2022;145:e153-e639. https://doi.org/10.1161/CIR.0000000000001052
- Whiteley W, Chong WL, Sengupta A, Sandercock P. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 2009;40: e380-e389. https://doi.org/10.1161/STROKEAHA.108.528752
- Tarride J-E, Lim M, DesMeules M, Luo W, Burke N, O'Reilly D, et al. A review of the cost of cardiovascular disease. Can J Cardiol. 2009;25:e195-e202. https://doi.org/10.1016/S0828-282X(09)70098-4
- Hijazi Z, Wallentin L, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, et al. Screening of multiple biomarkers associated with ischemic stroke in atrial fibrillation. J Am Heart Assoc. 2020;9:e018984. https://doi.org/10.1161/JAHA.120.018984
- Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, Davis EM, et al. Screening for atrial fibrillation: US preventive services task force recommendation statement. JAMA. 2022;327:360-367. https://doi.org/10.1001/jama.2021.23732
- Singleton MJ, Yuan Y, Dawood FZ, Howard G, Judd SE, Zakai NA, et al. Multiple blood biomarkers and stroke risk in atrial fibrillation: the regards study. J Am Heart Assoc. 2021;10:e020157. https://doi.org/10.1161/JAHA.120.020157
- Kang H. Statistical considerations in meta-analysis. Hanyang Med Rev. 2015;35:23-32. https://doi.org/10.7599/hmr.2015.35.1.23
- Nahm FS. Understanding effect sizes. Hanyang Med Rev. 2015;35:40-43. https://doi.org/10.7599/hmr.2015.35.1.40
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021;10:89. https://doi.org/10.1186/s13643-021-01626-4
- Ottawa Hospital Research Institute. 2021. [Internet]. Ottawa: Canada; 2021 [cited 2022 December 16]. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
- Harpaz D, Bajpai R, Ng GJL, Soljak M, Marks RS, Cheung C, et al. Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients. Heart Rhythm. 2021;18:855-861. https://doi.org/10.1016/j.hrthm.2021.01.032
- Ramos-Pachon A, Lopez-Cancio E, Bustamante A, Perez de la Ossa N, Millan M, Hernandez-Perez M, et al. D-dimer as predictor of large vessel occlusion in acute ischemic stroke. Stroke. 2021;52:852-858. https://doi.org/10.1161/strokeaha.120.031657
- Zhao J, Zhang Y, Yuan F, Song C, Jiang Y, Gao Q, et al. Diagnostic value of N-terminal pro B-type natriuretic peptide for nonvalvular atrial fibrillation in acute ischemic stroke patients: a retrospective multicenter case-control study. J Neurol Sci. 2020;414:116822. https://doi.org/10.1016/j.jns.2020.116822
- Garcia-Carmona JA, Conesa-Garcia E, Vidal-Mena D, GonzalezMorales M, Ramos-Arenas V, Sanchez-Vizcaino-Buendia C, et al. Increased plasma levels of N-terminal pro-B-type natriuretic peptide as biomarker for the diagnosis of cardioembolic ischaemic stroke. Neurologia. 2022. In Press. https://doi.org/10.1016/j.nrl.2021.09.014
- Zhang M, Wang Y, Wang J, Li X, Ma A, Pan X. Serum LRG1 as a novel biomarker for cardioembolic stroke. Clinica Chimica Acta. 2021;519:83-91. https://doi.org/10.1016/j.cca.2021.04.002
- Yang X, Lu T, Qu Z, Zhang Y, Liu P, Ma Y. Plasma D-dimer level is associated with clinical outcomes in patients with atrial fibrillation related acute ischemic stroke after pneumonia. BMC Neurol. 2021;21:137. https://doi.org/10.1186/s12883-021-02168-x
- Marta-Enguita J, Navarro-Oviedo M, Rubio-Baines I, Aymerich N, Herrera M, Zandio B, et al. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke. J Neuroinflammation. 2021;18:3. https://doi.org/10.1186/s12974-020-02047-1
- Da Silva-Candal A, Dopico-Lopez A, Perez-Mato M, RodriguezYanez M, Pumar JM, avila-Gomez P, et al. Characterization of a temporal profile of biomarkers as an index for ischemic stroke onset definition. J Clin Med. 2021;10:3136. https://doi.org/10.3390/jcm10143136
- Mengozzi M, Kirkham FA, Girdwood EER, Bunting E, Drazich E, Timeyin J, et al. C-reactive protein predicts further ischemic events in patients with transient ischemic attack or lacunar stroke. Front Immunol. 2020;11:1403. https://doi.org/10.3389/fimmu.2020.01403
- Chen CH, Chu HJ, Hwang YT, Lin YH, Lee CW, Tang SC, et al. Plasma neurofilament light chain level predicts outcomes in stroke patients receiving endovascular thrombectomy. J Neuroinflammation. 2021;18:195. https://doi.org/10.1186/s12974-021-02254-4
- Ma J, Shen L, Bao L, Yuan H, Wang Y, Liu H, et al. A novel prognosis prediction model, includin cytotoxic T lymphocyte-associated antigen-4, ischemia-modified albumin, lipoprotein-associated phospholipase A2, glial fibrillary acidic protein, and homocysteine, for ischemic stroke in the Chinese hypertensive population. J Clin Lab Anal. 2021;35:e23756. https://doi.org/10.1002/jcla.23756
- Dong S, Pei B, Xie W, Wang J, Zeng Q. Anticardiolipin antibody and anti-β2 glycoprotein I antibody are potential risk markers of ischaemic stroke in Chinese adults. Rheumatology (Oxford). 2020;59:1834-1841. https://doi.org/10.1093/rheumatology/kez551
- Chen Z, Hu Q, Huo Y, Zhang R, Fu Q, Qin X. Serum interleukin-33 is a novel predictive biomarker of hemorrhage transformation and outcome in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2021;30:105506. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105506
- Schwedhelm E, von Lucadou M, Peine S, Lezius S, Thomalla G, Boger R, et al. Trimethyllysine, vascular risk factors and outcome in acute ischemic stroke (MARK-STROKE). Amino Acids. 2021;53:555-561. https://doi.org/10.1007/s00726-021-02969-x